EDA2R and Skeletal muscle atrophy: Collectively, these studies establish EDA2R as a central mediator of muscle wasting in both sarcopenia and cachexia and highlight its potential as a therapeutic target to mitigate muscle degeneration associated with ageing and chronic illness.